XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 15,174 $ 65,173
Short-term investments 102,485 159,132
Trade receivables, net 59,864 65,449
Gross inventories 150,192 129,294
Less LIFO reserve (64,262) (59,489)
Less excess and obsolescence reserve (6,120) (4,812)
Net inventories 79,810 64,993
Prepaid expenses and other current assets 14,062 7,091
Total Current Assets 271,395 361,838
Property, plant and equipment 462,397 447,126
Less allowances for depreciation (390,863) (370,273)
Net property, plant and equipment 71,534 76,853
Deferred income taxes 11,976 6,109
Other assets 43,912 39,963
Total Assets 398,817 484,763
Current Liabilities    
Trade accounts payable and accrued expenses 31,708 35,658
Dividends payable 88,343
Contract liabilities with customers (Note 2) 149 1,031
Product liability 634 235
Employee compensation and benefits 24,660 30,160
Workers’ compensation 6,044 6,469
Income taxes payable 1,171
Total Current Liabilities 63,195 163,067
Lease liability (Note 7) 2,170 3,039
Employee compensation 1,685 1,846
Product liability accrual 46 73
Contingent liabilities (Note 20)
Stockholders’ Equity    
Additional paid-in capital 46,849 45,075
Retained earnings 418,058 393,097
Treasury stock (157,623) (145,812)
Total Stockholders’ Equity 331,721 316,738
Total Liabilities and Stockholders’ Equity 398,817 484,763
Nonvoting Common Stock    
Stockholders’ Equity    
Authorized shares – 50,000; none issued
Common Stock    
Stockholders’ Equity    
Authorized shares – 50,000; none issued $ 24,437 $ 24,378